A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 1, 2010, Pages 24-28

  Zhuang, Xuewei ^a,b   Xia, Xiyan ^c   Wang, Chuanxin ^b   Gao, Fei ^d   Shan, Ningning ^b   Zhang, Lei ^d   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Health School of Jinan   (China)

^d BEIJING HOSPITAL   (China)

Author keywords

CD8+ T cells; NSCLC; Prognosis

Indexed keywords

ARTICLE; CANCER TISSUE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE;

CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; PROGNOSIS; SURVIVAL RATE;

EID: 76149124214     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181b6a741     Document Type: Article

References (24)

1. Ginsberg RJ, Vokes EE, Raben A. Non-small cell lung cancer. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott-Raven Publishers; 2001: 858-910.
2. Rohrer JW, Coggin JH. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J Immunol. 1995; 155:5719-5727.
3. Rosenberg SA. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens. Annu Rev Med. 1996;47:481-491.
4. Underwood JC. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer. 1974;30:538-548.
5. Mukai S, Kjaergaard J, Shu S, et al. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res. 1999;59:5245-5249.
6. Willimsky G, Blankenstein T. Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors. Cancer Res. 2000;60:685-692.
7. Riemann D, Wenzel K, Schulz T, et al. Phenotypic analysis of T lymphocytes isolated from non-small cell lung cancer. Int Arch Allergy Immunol. 1997;114:38-45.
8. House AK, Watt AG. Survival and the immune response in patients with carcinoma of the colorectum. Gut. 1979;20: 868-874.
9. Balch CM, Riley LB, Bae YJ, et al. Patterns of human tumorinfiltrating lymphocytes in 120 human cancers. Arch Surg. 1990;125:200-205.
10. Boon T, Coulie PG, Van den Eynde B. Tumor antigens recognized by T cells. Immunol Today. 1997;18:267-268.
11. Yoshino I, Takenoyama M, Fujie H, et al. The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer. Jpn J Cancer Res. 1997;88:743-749.
12. Naito Y, Saito K, Shiiba K, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58:3491-3494.
13. Schumacher K, Haensch W, Roefzaad C, et al. Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas. Cancer Res. 2001;61:3932-3936.
14. Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+ T cells and CD4+T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer. 2006;94: 275-280.
15. Eerola AK, Soini Y, Paakko P. Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma. Lung Cancer. 1999;26: 73-83.
16. Eerola AK, Soini Y, Paakko P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res. 2000;6:1875-1881.
17. Mori M, Ohtani H, Naito Y, et al. Infiltration of CD8+ T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis. Tohoku J Exp Med. 2000;191:113-118.
18. Johnson SK, Kerr KM, Chapman AD, et al. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer. 2000;27:27-35.
19. WHO. Histological typing of lung tumours ed 2. Am J Clin Pathol. 1982;77:123-136.
20. Boon T, Cerottini JC, Van den Eynde B, et al. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12: 337-365.
21. Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 1999;10:281-287.
22. Yamazaki K, Spruill G, Rhoderick J, et al. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2. Cancer Res. 1999;59:4642-4650.
23. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev. 2002;13:143-154.
24. Turk MJ, Guevera-Patino JA, Rzzuto GA. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med. 2004;200:771-782.